Deulumateperone clinical trials
Also written ITI-1284.
How each study uses deulumateperone is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the deulumateperone studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
8 studies that test it; most in 2024 (5)
| Year | Studies |
|---|---|
| 2024 | 5 |
| 2025 | 1 |
| 2026 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 8 · Other 0
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 2
Studies that test deulumateperone.
- Mar 2027Study of ITI-1284 as an Adjunctive Treatment in Patients With Generalized Anxiety DisorderPhase 2 · Intra-Cellular Therapies, Inc.
- Oct 2027Study of ITI-1284 as Monotherapy Treatment in Patients With Generalized Anxiety DisorderPhase 2 · Intra-Cellular Therapies, Inc.
Studies
Open first, then newest update. How each study uses deulumateperone is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 8
- A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Agitation Associated With Alzheimer's DementiaRecruitingPhase 2Intra-Cellular Therapies, Inc.NCT06651567Written as ITI-1284
- Study of ITI-1284 as Monotherapy Treatment in Patients With Generalized Anxiety DisorderRecruitingPhase 2Intra-Cellular Therapies, Inc.NCT06701903Written as ITI-1284 10 mg
- Study of ITI-1284 as an Adjunctive Treatment in Patients With Generalized Anxiety DisorderRecruitingPhase 2Intra-Cellular Therapies, Inc.NCT06480383Written as ITI-1284 10 mg
- A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's DiseaseRecruitingPhase 2Intra-Cellular Therapies, Inc.NCT06540833Written as ITI-1284
- A Study to Asses Safety and Tolerability of ITI-1284 Given Alone or as an Additional Treatment in Participants With Generalized Anxiety Disorder (GAD)RecruitingPhase 3Intra-Cellular Therapies, Inc.NCT07807865Written as ITI-1284
- A Study of JNJ-99245354 (ITI-1284) as an Adjunctive Treatment in Participants With Generalized Anxiety Disorder (GAD) Who Have an Inadequate Response to GAD TreatmentRecruitingPhase 3Intra-Cellular Therapies, Inc.NCT07856420Written as JNJ-99245354
- PET Study to Evaluate Brain Receptor Occupancy, Safety and Pharmacokinetics of ITI-1284 in Healthy SubjectsCompletedPhase 1Intra-Cellular Therapies, Inc.NCT06299410Written as ITI-1284 10 mg
- A Mass Balance Study Following Subcutaneous Administration of [14C]-ITI-1284 to Healthy Male SubjectsCompletedPhase 1Intra-Cellular Therapies, Inc.NCT06786286Written as [14C]-ITI-1284
Codes
What other systems call deulumateperone · ClinicalTrials.gg INT017375
- UNII (FDA) NBA7J58PPPDEULUMATEPERONEConfirmed FDA, Wikidata
- Wikidata Q133270376deulumateperoneConfirmed FDA, Wikidata
- NCI Thesaurus C216017DeulumateperoneOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | NBA7J58PPP | DEULUMATEPERONE | Confirmed FDA, Wikidata |
| Wikidata | Q133270376 | deulumateperone | Confirmed FDA, Wikidata |
| NCI Thesaurus | C216017 | Deulumateperone | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.